You have 9 free searches left this month | for more free features.

erlotinib

Showing 26 - 50 of 325

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

NSCLC, Carcinoma, Small Cell Lung, Carcinoma, Thymic Trial run by the National Cancer Institute (NCI) (AZD6244, MK-2206,

Active, not recruiting
  • Carcinoma, Non-Small-Cell Lung
  • +2 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
Aug 24, 2022

Rare Tumor, Refractory Tumor Trial in Shanghai (Gefitinib, Erlotinib, Afatinib)

Recruiting
  • Rare Tumor
  • Refractory Tumor
  • Shanghai, Shanghai, China
    Shanghai Changzheng Hospital
Feb 16, 2022

NSCLC Trial in Badalona, Málaga (Docetaxel, Cisplatin, Gemcitabine)

Completed
  • Non-small Cell Lung Cancer
  • Badalona, Barcelona, Spain
  • +1 more
Jun 8, 2022

NSCLC Trial in Canada, United States (Nivolumab, Gemcitabine, Cisplatin)

Completed
  • Non-small Cell Lung Cancer
  • Nivolumab
  • +8 more
  • Los Angeles, California
  • +11 more
Sep 20, 2021

Locally Advanced Pancreatic Cancer, Metastatic Pancreatic Cancer Trial in Amsterdam (gemcitabine, erlotinib, metformin)

Completed
  • Locally Advanced Pancreatic Cancer
  • Metastatic Pancreatic Cancer
  • Amsterdam, Netherlands
    Academic Medical Center
Apr 19, 2021

Cancer, Tumors, Tumors Trial in Denmark (Alectinib, Atezolizumab, Avelumab)

Recruiting
  • Cancer
  • +3 more
  • Aalborg, Denmark
  • +6 more
Oct 25, 2022

Metastatic Breast Cancer Trial in United States (Fulvestrant, erlotinib, Placebo)

Terminated
  • Metastatic Breast Cancer
  • Jonesboro, Arkansas
  • +5 more
Mar 26, 2021

Cancer, Non Small Cell Lung Cancer Trial in Salt Lake City (PET Imaging, Erlotinib, Bevacizumab)

Completed
  • Cancer
  • Non Small Cell Lung Cancer
  • PET Imaging
  • +2 more
  • Salt Lake City, Utah
    Huntsman Cancer Institute
Dec 16, 2021

Breast Cancer, Breast Tumors, Colon Cancer Trial in United States (AZD6244, Dacarbazine, Erlotinib)

Active, not recruiting
  • Breast Cancer
  • +7 more
  • Detroit, Michigan
  • +3 more
Dec 22, 2022

Brain Cancer Trial in Basking Ridge, Commack, New York (erlotinib, Cytoreductive Surgery)

Completed
  • Brain Cancer
  • erlotinib
  • Cytoreductive Surgery
  • Basking Ridge, New Jersey
  • +3 more
Jan 6, 2021

Lung Tumor Trial in São Paulo (Alectinib, Pembrolizumab, Nivolumab)

Active, not recruiting
  • Lung Neoplasm
  • São Paulo, Brazil
    Hospital Municipal Vila Santa Catarina
Oct 5, 2021

NSCLC Trial in Netherlands (erlotinib plus docetaxel or pemetrexed, erlotinib)

Completed
  • Carcinoma, Non-Small-Cell Lung
  • erlotinib plus docetaxel or pemetrexed
  • erlotinib
  • Amsterdam, Netherlands
  • +13 more
Sep 25, 2020

Neuroendocrine Tumors Trial in San Francisco (RAD001, erlotinib)

Terminated
  • Neuroendocrine Tumors
  • San Francisco, California
    University of California, San Francisco
Sep 27, 2020

Non Small Cell Lung Cancer Trial in United States (Stereotactic Radiosurgery, Erlotinib)

Completed
  • Non Small Cell Lung Cancer
  • Stereotactic Radiosurgery
  • Erlotinib
  • San Francisco, California
  • +7 more
Dec 17, 2020

Polycythemia Vera Trial in Oklahoma City (Erlotinib)

Terminated
  • Polycythemia Vera
  • Erlotinib
  • Oklahoma City, Oklahoma
    University of Oklahoma Health Sciences Center
Aug 7, 2020

Non-squamous NSCLC Trial in Italy (Erlotinib, Bevacizumab)

Active, not recruiting
  • Non-squamous Non-small Cell Lung Cancer
  • Carpi, MO, Italy
  • +54 more
Mar 3, 2021

Lymphoma, Non-Hodgkin, Multiple Myeloma, Advanced Solid Tumors Trial in Canada (Olaparib, Dasatinib, Nivolumab plus Ipilimumab)

Recruiting
  • Lymphoma, Non-Hodgkin
  • +2 more
  • Edmonton, Alberta, Canada
  • +9 more
Jan 9, 2023

Non Small Cell Lung Cancer Trial in Worldwide (RAD001, erlotinib)

Completed
  • Non Small Cell Lung Cancer
  • Atlanta, Georgia
  • +13 more
Dec 17, 2020

Lung Cancer Trial in Aurora, Dallas (Erlotinib, SBRT)

Completed
  • Lung Cancer
  • Erlotinib
  • SBRT
  • Aurora, Colorado
  • +1 more
Aug 19, 2020

Cancer, Advanced Solid Tumors Trial in Amsterdam (Sunitinib, Sorafenib, Erlotinib)

Completed
  • Cancer
  • Advanced Solid Tumors
  • Amsterdam, Netherlands
    VUMedical Center
Apr 14, 2021

NSCLC Stage IIIA Trial in Guangzhou (Almonertinib, Erlotinib, Cisplatin)

Not yet recruiting
  • Non-Small Cell Lung Cancer Stage IIIA
  • Guangzhou, China
    The First Affiliated Hospital of Guangzhou Medical University
Jun 30, 2020

Advanced Cancer Trial in Houston (Bevacizumab, Sorafenib, Erlotinib)

Completed
  • Advanced Cancer
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Jun 27, 2020

NSCLC Trial in United States (Erlotinib, Hydroxychloroquine)

Unknown status
  • Non-small Cell Lung Cancer
  • Stanford, California
  • +3 more
Jul 1, 2020

Advanced Solid Tumor, NSCLC, Colorectal Cancer Trial in Australia, United States (LY3499446, Abemaciclib, Cetuximab)

Terminated
  • Advanced Solid Tumor
  • +2 more
  • Indianapolis, Indiana
  • +5 more
Oct 27, 2021

NSCLC Trial in Worldwide (Ficlatuzumab, Erlotinib, )

Terminated
  • Non-small Cell Lung Cancer
  • Fresno, California
  • +46 more
Oct 20, 2020